Condition
Multiple Sclerosis (MS) - Relapsing-remitting clinical trials and research
As of November 12, 2026, Find a Trial lists 11 Multiple Sclerosis (MS) - Relapsing-remitting clinical trials that are recruiting, at sites in 4 countries (most in United States (7), Turkey (Türkiye) (2), United Kingdom (1)). 1 was first registered in the last 30 days. By phase: Phase 4 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 1New in 30 days
- 4Countries
Newest Multiple Sclerosis (MS) - Relapsing-remitting clinical trials
All recruiting trials (11)
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Brain Imaging and Immune Changes During Remibrutinib in Relapsing MS
This study tests how remibrutinib affects brain inflammation in people with relapsing MS who are also on ocrelizumab.
-
Wearable focal vibration to improve arm and hand function in relapsing-remitting MS
This pilot will try a home-based wearable focal vibration device on arm muscles to see if it improves arm and hand function in adults with relapsing-remitting multiple sclerosis.
-
Home-based functional balance program for people with multiple sclerosis
This project will test whether a home-based functional balance program helps adults with multiple sclerosis improve physical and cognitive function and daily activities.
-
Monthly blood monitoring of neurofilament light to detect hidden activity in treated relapsing-remitting MS
This will test whether monthly blood measurements of neurofilament light (pNfL) can find hidden disease activity in people with treated relapsing-remitting MS.
-
Combining mental rehearsal and vestibular therapy for relapsing‑remitting MS
This trial tests whether adding motor imagery (mental rehearsal) to vestibular rehabilitation improves balance, thinking, and quality of life in adults 18–45 with relapsing‑remitting MS who have mild cognitive and balance problems.
-
Ublituximab (Briumvi) for early relapsing MS
This study will test whether giving Ublituximab (Briumvi) about twice a year is safe and changes a blood marker (neurofilament light) in adults with early relapsing MS.
-
Using short selfie videos to measure walking and speech changes in people with MS
This project will test whether short selfie videos taken by people with MS can reliably show walking and speech changes similar to what clinicians see in person.
-
Sexual problems in women with relapsing-remitting multiple sclerosis
See if sexual dysfunction is common in women aged 25-50 with relapsing-remitting MS and whether it's linked to fatigue, mood, bladder symptoms, and cognitive problems.
-
Retinal OCT biomarkers for ublituximab response in relapsing MS
We will test whether special retinal OCT scans can find signs of immune activity in people with relapsing MS who are starting ublituximab or already on a stable MS medication.
-
Ublituximab for walking and motor function in relapsing multiple sclerosis
This study will test whether ublituximab improves walking, balance, and thinking in people with relapsing‑remitting multiple sclerosis.
Related topics
Quick answers
How many Multiple Sclerosis (MS) - Relapsing-remitting clinical trials are recruiting right now?
11, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (7 trials), Turkey (Türkiye) (2 trials), United Kingdom (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.